Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sectra AB's change in receivables for the quarter that ended in Apr. 2026 was €5.1 Mil. It means Sectra AB's Accounts Receivable
declined by €5.1 Mil
from Jan. 2026 to Apr. 2026 .
Sectra AB's change in receivables for the fiscal year that ended in Apr. 2026 was €-14.9 Mil. It means Sectra AB's Accounts Receivable
increased by €14.9 Mil
from Apr. 2025 to Apr. 2026 .
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Sectra AB's Days Sales Outstanding for the
three
months ended in Apr. 2026 was 63.79.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Sectra AB's liquidation value for the
three
months ended in Apr. 2026 was €3.5 Mil.
Sectra AB (MIL:1SECT) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Sectra AB's Days Sales Outstanding for the quarter that ended in Apr. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sectra AB Change In Receivables Related Terms
Sectra AB Change In Receivables Historical Data
* Premium members only.
The historical data trend for Sectra AB's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-15.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Change In Receivables of €-15.3 Mil mean?
Sectra AB (MIL:1SECT) has a Change In Receivables of €-15.3 Mil as of Apr. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Sectra AB and its competitors.
Is Sectra AB's Change In Receivables too high?
Sectra AB's current Change In Receivables is €-15.3 Mil. Overall, Sectra AB has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sectra AB's Change In Receivables compare to ABT and SYK?
Sectra AB's Change In Receivables of €-15.3 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Medical Devices & Instruments company?
A good Change In Receivables depends on the Medical Devices & Instruments industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Sectra AB and its competitors. Sectra AB's current Change In Receivables is €-15.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sectra AB stock overvalued right now?
Based on GuruFocus' analysis, Sectra AB (MIL:1SECT) is currently considered Fairly Valued. The stock's GF Value™ is €30.08, compared to a current price of €27.38 — trading 9% below its estimated fair value. The current Change In Receivables is €-15.3 Mil. Sectra AB's overall GF Score™ is 74/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Sectra AB (MIL:1SECT), the current Change In Receivables is €-15.3 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sectra AB (MIL:1SECT) Overvalued in 2026?
Based on GuruFocus' analysis, Sectra AB stock appears to be undervalued.
The current stock price of €27.38 is trading 9% below its estimated GF Value™ of €30.08.
GuruFocus considers Sectra AB to be Fairly Valued.
Key valuation signals for MIL:1SECT:
Change In Receivables: €-15.3 Mil
GF Value™: €30.08 vs. price of €27.38 (9% below fair value)
No single metric tells the full story. See the MIL:1SECT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sectra AB develops IT solutions and services for storing, viewing, and working with medical images. The operating business segments are Imaging IT Solutions, Secure Communications, Business Innovation, and Other Operations. It generates maximum revenue from the Imaging IT Solutions segment. The company also offers maintenance in the form of support, system monitoring, and consulting services related to integration, system design, data migration, and business development. Geographically, it derives a majority of its revenue from the United States, followed by Sweden, the United Kingdom, the Netherlands, the Rest of Europe, and the Rest of the world.
74GF Score
Get the complete analysis for MIL:1SECT
Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1SECT has been successfully added to your 
